Furthermore, this study revealed that the overexpression of K-Ras in MSCs and lymphocytes activated PI3K/Akt and PKA/CREB signaling pathways, and their activation by pharmacological agents also generated tumor-suppressive CM. Here, KRAS is linked to neoplasm.